Frazier Lifesciences Acquisition Corporation Warrant
FLACW
FLACW was delisted on the 22nd of November, 2022.
30 hedge funds and large institutions have $1.83M invested in Frazier Lifesciences Acquisition Corporation Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
3% more funds holding
Funds holding: 29 → 30 (+1)
23% less capital invested
Capital invested by funds: $2.38M → $1.83M (-$557K)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$72.4K |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
+$16.3K |
| 3 |
EAM
Exos Asset Management
New York
|
+$1.54K |
| 4 |
BCM
Bluefin Capital Management
New York
|
+$96 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$21K |
| 2 |
CAC
Cowen and Company
New York
|
-$19.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.99K |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$3.4K |
| 5 |
DCM
DG Capital Management
New York
|
-$2.91K |
FLACW Hedge Fund Activity: Q1 2022 in Review
30 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Warrant (FLACW) for Q1 2022, worth a combined $1.83M — down 23% from $2.38M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FLACW positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $72.4K. The largest seller was Picton Mahoney Asset Management, exiting entirely with an estimated $21K sold.
- 30 institutional investors held Frazier Lifesciences Acquisition Corporation Warrant (FLACW) as of Q1 2022, up from 29 in Q4 2021.
- Funds reported $1.83M of Frazier Lifesciences Acquisition Corporation Warrant stock for Q1 2022, down 23% quarter-over-quarter.
- 2 funds opened new Frazier Lifesciences Acquisition Corporation Warrant positions in Q1 2022 and 1 closed out, a net change of +1 holder.
- The largest Frazier Lifesciences Acquisition Corporation Warrant buyer in Q1 2022 was Goldman Sachs, an estimated $72.4K added.
- The largest Frazier Lifesciences Acquisition Corporation Warrant seller in Q1 2022 was Picton Mahoney Asset Management, an estimated $21K sold.
Based on aggregated 13F filings for Q1 2022.